Stay updated on Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial page.

Latest updates to the Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedFooter updates include adding Revision: v3.3.3 and removing Revision: v3.3.2 plus removing the HHS Vulnerability Disclosure text, which are minor metadata changes that do not affect study content or user interaction. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe record history shows a new revision entry v3.3.2 and the older revision v3.3.1 is removed from the listing.SummaryDifference0.0%

- Check42 days agoChange DetectedA new entry Revision: v3.3.1 was added to the history, and the entry Revision: v3.2.0 was removed.SummaryDifference0.0%

- Check49 days agoChange DetectedThe government funding/operating status notice was removed from the page. This removes guidance about data freshness and NIH operating status.SummaryDifference0.3%

- Check63 days agoChange DetectedA new version entry dated 2024-09-18 was added to the study record history, increasing the number of listed versions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference8%

Stay in the know with updates to Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial page.